Administration of donor-derived transplant acceptance-inducing cells to the recipients of renal transplants from deceased donors is technically feasible

Clinical Transplantation

Volumn 23, Issue 1, 2009, Pages 140-145

  Hutchinson, James A ^a   Gövert, Felix ^a   Riquelme, Paloma ^a   Bräsen, Jan Hinrich ^a   Brem Exner, Beate G ^a   Matthäi, Martina ^a   Schulze, Maren ^a   Renders, Lutz ^a   Kunzendorf, Ulrich ^a   Geissler, Edward K ^b   Fändrich, Fred ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Cell based immunotherapy; Regulatory macrophage

Indexed keywords

CREATININE; PREDNISOLONE; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ARTICLE; CADAVER KIDNEY; CASE REPORT; CELL THERAPY; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEASIBILITY STUDY; FEMALE; GRAFT RECIPIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MONOTHERAPY; PRIORITY JOURNAL; URINARY TRACT OBSTRUCTION;

ADULT; CADAVER; FEASIBILITY STUDIES; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; TACROLIMUS; TISSUE DONORS; TISSUE THERAPY; TRANSPLANTATION CONDITIONING; TRANSPLANTATION TOLERANCE;

EID: 63349100101     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2008.00953.x     Document Type: Article

References (26)

1. Fändrich F, Lin X, Chai GX et al. Preimplantation-stage stem cells induce allogeneic graft tolerance without supplementary host conditioning. Nat Med 2002: 8: 171.
2. Fändrich F, Zhou X, Schlemminger M, Glass B, Lin X, Dreßke B. Future strategies for tolerance induction: A comparative study between hematopoietic stem cells and macrophages. Hum Immunol 2002: 63: 805.
3. Hutchinson JA, Riquelme P, Brem-Exner BG et al. Transplant acceptance-inducing cells as an immune-conditioning therapy in renal transplantation. Transpl Int 2008: 21: 728.
4. Heumann A, Ungefroren H, Ruhnke M et al. Charakterisierung nichtdendritischer monozytärer Zellen mit Immunregulatorischen Eigenschaften. Deutsche Gesellschaft für Chirurgie. Chir Forum 2005. [abstract]. 2005: 34: 271.
5. Exner BG, Scherer MN, Koehl GE et al. Hyperacute rejection of transplanted rat hearts is abrogated by the use of in vitro generated donor-derived transplant-acceptance-inducing cells (TAIC). Transplantation 2004: 78(Suppl. 1): 530.
6. B rem -E xner BG, S attler C, H utchinson JA et.al. Macrophages driven to a novel state of activation have anti-inflammatory properties in mice. J Immunol 2008: 180: 335.
7. Burlingham W, Kuska S, Chin L et al. Focal infiltrates in kidney allografts -Developing a model for clinical transplant peripheral tolerance. Graft 1999: 2: 253-260.
8. Coupes BM, Speake M, Johnson RWG, Roberts ISD, Campbell B, Short CD. Tacrolimus monotherapy in renal transplantation: Four-year data. Transplant Proc 2002: 34: 1612.
9. Shapiro R, Jordan ML, Basu A et al. Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg 2003: 238: 520-27.
10. Starzl TE, Murase N, Abu-Elmagd K et al. Tolerogenic immunosuppression for organ transplantation. Lancet 2003: 361: 1502.
11. Tan HP, Kaczorowski D, Basu A et al. Steroid-free monotherapy after pretransplantation thymoglobulin or Campath and laparoscopy in living donor renal transplantation. Transplant Proc 2005: 37: 4235.
12. Krämer BK, Krüger B, Mack M et al. Steroid withdrawal or steroid avoidance in renal transplant recipients: Focus on tacrolimus-based immunosuppressive regimens. Transplant Proc 2005: 37: 1789.
13. Tan HP, Kaczorowski DJ, Basu A et al. Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. Am J Transplant 2006: 6: 2409.
14. Bäckman L, Åselius H,Lindberger K et al. Steroid-free immunosuppression in kidney transplant recipients and prograf monotherapy: An interim analysis of a prospective multicenter trial. Transplant Proc 2006: 38: 2654-56.
15. Thomas PG, Woodside KJ, Lappin JA et al. Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation. Transplantation 2007: 83: 1509.
16. Van Furth R, Diesselhoff-den Dulk MM. Dual origin of mouse splenocytes. J Exp Med 1984: 160: 1273.
17. van Rooijen N, Kors N, Kraal G. Macrophage subset repopulation in the spleen: Differential kinetics after liposome-mediated elimination. J Leukoc Biol 1989: 45: 97.
18. Bouwens L, Baekeland M, De Zanger R et al. Quantitation, tissue distribution and proliferation kinetics of Kupffer cells in normal rat liver. Hepatology 1986: 6: 718.
19. Van Rooijen N, Kors N, vd Ende M et al. Depletion and repopulation of macrophages in spleen and liver of rat after intravenous treatment with liposome-encapsulated dichloromethylene diphosphonate. Cell Tissue Res 1990: 260: 215.
20. Ryan GB, Spector WG. Macrophage turnover in inflamed connective tissue. Proc R Soc Lond B Biol Sci 1970: 175: 269.
21. Bowers RR, Houston F, Clinton R et al. A histological study of the carrageenan-induced granuloma in the rat lung. J Pathol 1980: 132: 243.
22. Fehr T, Sykes M. Clinical experience with mixed chimerism to induce transplantation tolerance. Transpl Int 2008: 21: 1118.
23. Warnecke G, Hutchinson JA, Riquelme P et al. Postoperative intravenous infusion of donor-derived transplant acceptance-inducing cells as an adjunct immunosuppressive therapy in a porcine pulmonary allograft model. Transpl Int 2008 (in press).
24. Hutchinson JA, Brem-Exner BG, Riquelme P et al. A cell-based approach to the minimization of immunosuppression in renal transplantation. Transpl Int 2008: 21: 742.
25. Hutchinson JA, Roelen D, Riquelme P et al. Preoperative treatment of a presensitized kidney transplant recipient with donor-derived transplant acceptance-inducing cells. Transpl Int 2008: 21: 808.
26. Chatenoud L. The long and winding road towards induction of allograft tolerance in the clinic. Transpl Int 2008: 21: 725.